KATEY WALDON: Open Payments
NPI 1487017901 · FAYETTEVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,892 in 112 payments from 16 companies in 2025. Trend: 2023 $1,143 · 2024 $1,361 · 2025 $1,892
Food & beverage: $1,892
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $404 |
| Janssen Biotech, Inc. | 13 | $243 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 16 | $221 |
| UCB, Inc. | 8 | $185 |
| Regeneron Healthcare Solutions, Inc. | 10 | $174 |
| PFIZER INC. | 12 | $165 |
| GENZYME CORPORATION | 5 | $126 |
| Novartis Pharmaceuticals Corporation | 7 | $117 |
| E.R. Squibb & Sons, L.L.C. | 3 | $49 |
| Arcutis Biotherapeutics, Inc. | 3 | $48 |
Products named: SKYRIZI, TREMFYA, DUPIXENT, Bimzelx, CIBINQO, RINVOQ, ILUMYA, COSENTYX.
Industry payments across NY — which companies pay providers there.
